Related Experiment Videos
Experimental chemoimmunotherapy of cancer
Pharmacological Research Communications
|February 1, 1978
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Wine and tumors: study of resveratrol.
Drugs under experimental and clinical research·2004
Antisense oligonucleotide drug design.
Current pharmaceutical design·2004
Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect.
European journal of cancer (Oxford, England : 1990)·2001
Anti-inflammatory and peripheral analgesic activity of esculetin in vivo.
Pharmacological research communications·1988
Anti-inflammatory activity of Echinacea angustifolia fractions separated on the basis of molecular weight.
Pharmacological research communications·1988
BN-52021 protects guinea-pig from heart anaphylaxis.
Pharmacological research communications·1988
Sedative, anti-inflammatory and anti-diuretic effects induced in rats by essential oils of varieties of Anthemis nobilis: a comparative study.
Pharmacological research communications·1988
Effects of kassinin, a tachykinin of the skin of the African frog Kassina senegalensis, on body fluid homeostasis in rats.
Pharmacological research communications·1988
Effects of Trema guineense decoction on some metabolic activities in the rat.
Pharmacological research communications·1988
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026